title: Multicentre study of the treatment of primary liver cancer in Africa with two anthracycline drugs.
authors.affiliation: Department of Medicine, University of Zimbabwe, Avondale, Harare.
authors.forename: C F
authors.initials: CF
authors.lastname: Kiire
authors.forename: C
authors.initials: C
authors.lastname: Gombe-Mbalawa
authors.forename: E
authors.initials: E
authors.lastname: Tsega
authors.forename: J
authors.initials: J
authors.lastname: Luande
authors.forename: L V
authors.initials: LV
authors.lastname: Menenses
authors.forename: J
authors.initials: J
authors.lastname: Okoth
authors.forename: C L
authors.initials: CL
authors.lastname: Olweny
authors.forename: J
authors.initials: J
authors.lastname: Holland
mesh_terms: D000349:Africa; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D015251:Epirubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D016019:Survival Analysis
chemical_list: D015251:Epirubicin; D004317:Doxorubicin